IKA 2024: Diagnostic considerations for cataract surgery in keratoconus patients
May 19th 2024Elizabeth Yeu, MD, Executive Board Member of IKA, and a cataract and refractive surgeon at Virginia Eye Consultants, talked about cataract surgery in keratoconus, and the diagnostic considerations clinicians can take before and in the operating room.
IKA 2024: Treating keratoconus in the pediatric population
May 18th 2024Barry Eiden, OD, FAAO, FSLS, President and Co-founder of IKA, talked about his session at the meeting centering around the pediatric prevalence of keratoconus, the importance of early diagnosis, and the impact this can have on practices.
IKA 2024: Specialty contact lenses with diseased and sick eyes
May 18th 2024Christine Sindt, OD, FAAO, Clinical Professor of Ophthalmology and Visual Sciences at the University of Iowa School of Medicine, talked about her session at the meeting focusing on higher order aberrations and the correction of complicated optics on scleral contact lenses.
ARVO 2024: Dr. John Sheppard shares results from GOBI, MOJAVE trials
The 2 FDA registration trials for perfluorohexyloctane resulted in scientifically significant results for improvement of mild and moderate symptoms of dry eye disease.
ARVO 2024: Study shows NutriTears improves signs and symptoms of DED
Neda Gioia, OD, CNS, FOWNS, CFMP, details recent findings on the efficacy of the NutriTears supplement on dry eye symptoms.
CIME 2024: Inder Paul Singh, MD, and the interventional glaucoma mindset
Inder Paul Singh, MD, defines what it means to have an interventional mindset when it comes to glaucoma procedures and treatments during the Controversies in Modern Eye Care 2024 meeting.
CIME 2024: Identifying the constellation of signs and symptoms in TED
Kelsey Roelofs, MD, gives her best methods to identifying and diagnosing thyroid eye disease in her Controversies in Modern Eye Care 2024 presentation.
ARVO 2024: Myopia management in children takeaways from the BLINK2 study
David A. Berntsen, OD, PhD, FAAO, talks through his 2024 ARVO presentation on the BLINK2 study and the findings on axial growth after discontinuing soft multifocal contact lens wear.
CIME 2024: Confronting Demodex blepharitis with advanced treatment
Marc Bloomenstein, OD, FAAO, discusses how optometrists can proactively manage Demodex blepharitis by regularly examining eyelids, diagnosing the condition early, and offering treatments to effectively eradicate the mites and prevent future complications.